News
-
Alexza Pharmaceuticals has hired Peter W. Schineller as its new Senior VP and Chief Commercial Officer, responsible for global commercialization of the company’s Adasuve Staccato inhaled loxapine. The FDA approved Adasuve for the treatment of… Read more . . .
-
The University of East Anglia (UEA) Medical School will fund research to adapt a MRSA-specific antibiotic being developed by Procarta Biosystems into a nasal spray for decolonization of patients before major surgery, according to Procarta.… Read more . . .
-
In a joint meeting of the FDA’s Advisory Committee for Reproductive Health Drugs (ACRHD) and the Drug Safety and Risk Management Advisory Committee (DSaRM), panelists voted 12-9 that the risk of cancer from calcitonin outweigh… Read more . . .
-
The March 7 meeting of the FDA’s Pulmonary-Allergy Drugs Advisory Committee (PADAC) for discussion of the Breo Ellipta inhaler, has been postponed due to weather. As of March 6, the meeting on GSK’s application for… Read more . . .
-
The first issue of the Lancet Respiratory Medicine journal is now available online and in print. Volume 1, Issue 1 includes articles on the efficacy of ICS/LABA combination inhalers and on the appropriateness of GOLD… Read more . . .
-
A study published February 27, 2013 in PLOS ONE found that patients using the Asthmapolis remote inhaler monitoring system who received weekly email reports on their inhaler usage experienced significant reduction in symptoms and reported… Read more . . .
-
Delegates to RDD Europe 2013, which will take place May 21-24, will notice familiar features from past iterations of the event alongside several innovations designed to enhance the meeting experience. . . . Read more Read more . . .
-
According to Marinomed, the company’s Coldamaris anti-virus nasal spray has been approved in Canada as a “natural health product.” The over-the-counter product has been registered in Europe, where it is licensed to Boehringer Ingelheim, since… Read more . . .
-
OptiNose has selected Pharma Tech Industries (PTI) to fill capsules, load cartridges, and package completed delivery systems for NDA batches of its dry powder intranasal sumatriptan, according to Pharma Tech. In November 2012, OptiNose announced… Read more . . .
-
Prevacus, Inc., a 2012 spin-out from Florida State University, has entered into an agreement with The Institute for the Commercialization of Public Research for funding to support clinical development of Prevasol nasal spray. According to… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.